By Nick Lavars When Parkinson’s patients are diagnosed with the condition, there are still many unknowns around how the disease will develop and how it will impact their lives. While it is no crystal ball, a new blood test developed at Newcastle University and Cambridge University in the UK is offering hope of better patient...
by Tyrel Linkhorn, University of Toledo Clinicians may soon have a better way to predict which of their diabetic patients are most likely to develop kidney disease, allowing for earlier interventions that keep patients off lifelong dialysis or transplant waiting lists. In a study led by Dr. Rujun Gong, professor and director of kidney research...
by Champalimaud Centre for the Unknown A team of doctors and scientists from the Champalimaud Clinical Centre in Lisbon, Portugal, and the Netherlands Cancer Institute in Amsterdam, has shown that patients with “low” rectal cancer (that is, very close to the anus) who show no sign of tumors after a course of radio- and chemotherapy...
by Amy Mone, Johns Hopkins University Researchers at the Johns Hopkins Kimmel Cancer Center in Baltimore, working with colleagues in the Netherlands, developed a blood test that can predict recurrence of gastric cancer in patients after surgery. A description of their test, which is still experimental, was published online Jan. 27 in the journal Nature...
by Bob Yirka , Medical Xpress A team of researchers affiliated with multiple institutions in Massachusetts has discovered some of the precancerous milestones that can lead to breast cancer in women with a BRCA2 gene mutation. In their paper published in the journal Science Advances, the group describes their detailed analysis of breast tissue taken...
by Alzheimer’s Research UK Over a third of people would want to know they had Alzheimer’s disease 15 years before symptoms show, according to new findings from Alzheimer’s Research UK. The UK’s leading dementia research charity published a report, Detecting and diagnosing Alzheimer’s disease, revealing the public’s attitudes toward early detection and diagnosis of Alzheimer’s,...
by Flinders University Australian researchers have identified 107 genes that increase a person’s risk of developing the eye disease glaucoma, and developed a genetic test to detect those at risk of going blind from it. The research, led by QIMR Berghofer Medical Research Institute and Flinders University, has been published today in the journal Nature...
UNIVERSITY OF CALIFORNIA – LOS ANGELES HEALTH SCIENCES A UCLA-led study revealed a new way to predict which patients with “stable” heart failure — those who have heart injury but do not require hospitalization — have a higher risk of dying within one to three years. Although people with stable heart failure have similar characteristics,...
by Karolinska Institutet Tables illustrate three-year survival probabilities for people with dementia diagnosed in primary care. Dark green indicates a low risk of death while dark purple indicates a high risk of mortality within three years. Credit: Karolinska Institutet / Neurology Researchers at Karolinska Institutet and from the Netherlands have developed a simple tool that shows...
by American Association for Cancer Research Credit: CC0 Public Domain Commercial gene expression tests that guide treatment decisions for prostate cancer may not accurately predict risk of disease progression in African American patients, according to results published in Cancer Epidemiology, Biomarkers, and Prevention, a journal of the American Association for Cancer Research. “When a man is diagnosed with low-...
